Patents Examined by J. Witz
  • Treatment of Dupuytren's disease with collagenase
    Patent number: 5589171
    Abstract: Dupuytren's disease is treated by applying collagenase to the affected palmar fascia.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: December 31, 1996
    Assignee: Advance Biofactures of Curacao
    Inventor: Thomas L. Wegman
  • Anti-inflammatory factor, method of isolation, and use
    Patent number: 5352462
    Abstract: The invention relates to an anti-inflammatory factor isolated from milk and to methods for using this factor to remove adhered neutrophils from endothelial cells, to prevent the emigration of cells from the vasculature and to suppress the response of lymphocytes to foreign antigens.
    Type: Grant
    Filed: October 27, 1992
    Date of Patent: October 4, 1994
    Assignee: Stolle Research & Development Corporation
    Inventor: Lee R. Beck
  • Use of intratracheal administration of SOD to protect humans from lung injury due to hyperoxia and hyperventilation
    Patent number: 5116616
    Abstract: The subject invention provides a method of protecting a human from lung injury due to hyperoxia and hyperventilation which comprises intratracheally administering to the human an amount of free CuZnSOD effective to protect the human from lung injury due to hyperoxia and hyperventilation.
    Type: Grant
    Filed: April 29, 1991
    Date of Patent: May 26, 1992
    Assignee: Bio-Technology General Corp.
    Inventor: Amnon Gonenne
  • Biodegradation of aliphatic chloroethylene compounds
    Patent number: 5071755
    Abstract: A method of degrading halogenated aliphatic hydrocarbons is disclosed comprising incubating microorganisms capable of degrading halogenated aliphatic hydrocarbons by an aromatic degradative pathway together with the halogenated aliphatic hydrocarbons under conditions such that said aromatic degradative pathway is active.
    Type: Grant
    Filed: July 9, 1990
    Date of Patent: December 10, 1991
    Assignees: Ecova Corporation, The United States of America as represented by the Administrator of the Environmental Protection Agency
    Inventors: Michael J. K. Nelson, Al Willis J. Bourquin, Parmely H. Pritchard
  • Compositions containing LYCD and other topically active medicinal ingredients
    Patent number: 4942031
    Abstract: A composition comprising LYCD together with known topically active useful medicinal agents such as antiwrinkling, antibiotic, anticancer, antifungal, antiinflammatory, antiviral, steroid, and wound healing agents. The LYCD works together with the other active ingredients to achieve a synergistic result more effective than can be obtained from the topical agents individually, and more effective than could be predicted from the mere addition of the known efficacies of the individual ingredients.
    Type: Grant
    Filed: August 16, 1989
    Date of Patent: July 17, 1990
    Inventor: Robert H. Levin
  • Blood substitute
    Patent number: RE34077
    Abstract: A blood substitute suitable for replacing blood in mammalian subjects when performance of surgical procedures at hypothermic temperatures is described. The blood substitute comprises water, electrolytes at physiological concentration, dextran 40 at a concentration sufficient for the blood substitute to achieve a colloidal suspension having a fluid osmotic pressure essentially equivalent to mammalian plasma, HEPES buffer at a physiological pH, dextrose, magnesium ion at a concentration of about 0.01M and potassium ion at a concentration greater than 10 mEq per liter sufficient to prevent or arrest cardiac fibrillation. In one embodiment the blood substitute is a multi-solution system wherein the solutions comprise differing levels of the above-indicated componants and are administered sequentially to completely replace a subjects circulating blood.
    Type: Grant
    Filed: October 23, 1990
    Date of Patent: September 22, 1992
    Assignee: Cryomedical Sciences, Inc.
    Inventors: Paul E. Segall, Harold D. Waitz, Hal Sternberg